secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K
Filed at:   2024-11-13T23:59:59+00:00
Accession:  0001601830-24-000201
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Recursion shareholders approve stock issuance for Exscientia acquisition
------------------------------------------------------------------------

- Shareholders voted 99.77% in favor (250.9M votes for) of issuing Class A common stock for the Exscientia acquisition.
- Proposal 2 (adjournment) deemed unnecessary after approval; not presented at Special Meeting.
- Special Meeting held Nov 12, 2024; quorum achieved with 253.5M votes present (72.5% of total eligible).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183024000201/0001601830-24-000201-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183024000201/rxrx-20241112.htm
  HTML page:      https://secwatch.observer/filing/0001601830-24-000201

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer